November 2022 FDA Watch: Pace of New Approvals Slows
Though there were fewer new approvals last month, the impact of the products that did gain approval more than made up for the drop in volume.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article